Neurocrine Bio. (NBIX) PT Raised to $87 at SVB Leerink
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- Goldman data shows hedge funds cut leverage at fastest pace since March
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 145.35 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $145.35 | 52 Week High | $58.46 | |||
| Open | $145.35 | 52 Week Low | $31.25 | |||
| Day High | $145.35 | P/E | N/A | |||
| Day Low | $145.35 | EPS | $-0.69 | |||
| Volume | 2,319 | |||||
